PT - JOURNAL ARTICLE AU - Sushil Abraham AU - David Bain AU - John Bowers AU - Heidi Kenty AU - Victor Larivee AU - Francisco Leira AU - Jasmina Xie AU - Jonathan Tsang TI - Overview of Best Practices for Biopharmaceutical Technology Transfers AID - 10.5731/pdajpst.2015.01086 DP - 2015 Sep 01 TA - PDA Journal of Pharmaceutical Science and Technology PG - 645--649 VI - 69 IP - 5 4099 - http://journal.pda.org/content/69/5/645.short 4100 - http://journal.pda.org/content/69/5/645.full SO - PDA J Pharm Sci Technol2015 Sep 01; 69 AB - Technology transfer is a key foundational component in product commercialization. It is more than just the transfer of documents; it relates to all aspects of the transfer of knowledge and experience to the commercial manufacturing unit to ensure consistent, safe, and high-quality product. This is the first in a series of articles from the BioPhorum Operations Group (BPOG) member companies discussing best practices and benchmarking of biopharmaceutical technology transfer. In this article, we provide the common terminology developed by BPOG to accommodate both transferring and receiving organizations. We also review the key elements of a robust technology transfer business process, including critical milestones. Finally, we provide a brief overview of the articles in this series.